No­var­tis adds In­di­anapo­lis site to its man­u­fac­tur­ing ca­pac­i­ty for ra­di­oli­gand drug Plu­vic­to

No­var­tis has the go-ahead from the FDA to man­u­fac­ture its ra­dio­phar­ma­ceu­ti­cal Plu­vic­to at a new fa­cil­i­ty in In­di­anapo­lis, mark­ing a step to­ward ad­dress­ing bur­geon­ing de­mand …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER